Picture of Dynavax Technologies logo

DVAX — Dynavax Technologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Brief: Dynavax Reports Fourth Quarter And Full Year 2023 Financial Results And Provides Full Year 2024 Financial Guidance

Feb 22 (Reuters) - Dynavax Technologies Corp  DVAX.O :
    * DYNAVAX REPORTS FOURTH QUARTER AND FULL YEAR 2023
FINANCIAL
RESULTS AND PROVIDES FULL YEAR 2024 FINANCIAL GUIDANCE 
    * DYNAVAX TECHNOLOGIES CORP: QTRLY EARNINGS PER SHARE $0.00
    * DYNAVAX TECHNOLOGIES CORP: CASH POSITION INCREASED TO $742
MILLION AT YEAR END AND EXPECT TO BE CASH FLOW POSITIVE FOR FULL
YEAR 2024
    * DYNAVAX TECHNOLOGIES CORP: 2024 HEPLISAV-B NET PRODUCT
REVENUE
EXPECTED TO BE $265 - $280 MILLION

Further company coverage:  DVAX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Dynavax Technologies

See all news